{"id":7585,"date":"2022-09-21T22:19:01","date_gmt":"2022-09-21T22:19:01","guid":{"rendered":"https:\/\/www.cubasupport.ie\/latest\/?p=7585"},"modified":"2022-09-21T22:19:06","modified_gmt":"2022-09-21T22:19:06","slug":"cuba-strides-ahead-in-research-of-new-alzheimers-treatment","status":"publish","type":"post","link":"https:\/\/www.cubasupport.ie\/latest\/cuba-strides-ahead-in-research-of-new-alzheimers-treatment\/","title":{"rendered":"Cuba strides ahead in research of new Alzheimer\u2019s treatment"},"content":{"rendered":"\n<figure class=\"wp-block-image size-full\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"700\" height=\"457\" src=\"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/older-people.jpeg?resize=700%2C457&#038;ssl=1\" alt=\"\" class=\"wp-image-7586\" srcset=\"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/older-people.jpeg?w=700&amp;ssl=1 700w, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/older-people.jpeg?resize=300%2C196&amp;ssl=1 300w\" sizes=\"auto, (max-width: 700px) 100vw, 700px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Cuban scientists have announced the next stage of research on NeuralCIM, a neuroprotective drug for Alzheimer\u2019s disease and other forms of dementia.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Cuba continues to make major strides in medical research and development in spite of the US-imposed blockade and the challenges it poses, including in the case of the&nbsp;<a href=\"https:\/\/peoplesdispatch.org\/2022\/08\/10\/sanctions-fuel-the-fire-at-cubas-matanzas-oil-storage\/\">Matanzas&nbsp;<\/a>fire. In addition to the three approved, home-grown, COVID-19 vaccines, Cuban scientists have made progress with other treatments for other diseases as well. One of them is NeuralCIM \u2013 a neuroprotective drug showing positive results among patients suffering from Alzheimer\u2019s, Parkinson\u2019s, and ataxia. The drug is entering advanced phases of trials where treatment of Alzheimer\u2019s disease is concerned.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">NeuralCIM is a product for nasal use, which makes it easy to administer. \u201cWhat it does is prolong the life of cells of the nervous system a little more, so the symptoms are more spaced out, and the disease doesn\u2019t progress so rapidly,\u201d Cuban neurologist Hector Vera Cuesta told&nbsp;<a href=\"https:\/\/www.abrilabril.pt\/internacional\/cuba-desenvolve-com-exito-tratamento-contra-alzheimer-e-parkinson\">AbrilAbril<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Like many other scientists who followed the previous phases of the development of NeuralCIM, Vera believes that the results are extraordinary. If NeuralCIM was to confirm the good outcomes in the next stages, its contribution to the care of patients with Alzheimer\u2019s disease and other forms of dementia around the world would be enormous.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Although around 55 million people around the world suffer from some form of dementia, existing therapies are few and rely on prolonged use, which can lead to discontinuation of therapy in some patients. Adding a new product to the list would offer new hope for many of them, and their caregivers.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Dr Leslie P\u00e9rez Ruiz from the Center for Molecular Immunology (CIM), one of the institutions involved in the research and development of NeuralCIM, explained that the third phase of the trial would take place in Havana, while the fourth phase would cover the whole country. Approximately 413 people will be involved in the phase conducted in Havana, and 1,456 will take part in the trial once it is expanded to other localities, said P\u00e9rez to&nbsp;<a href=\"https:\/\/www.radiohc.cu\/especiales\/exclusivas\/296113-neuralcim-farmaco-neuroprotector-para-tratamiento-del-alzheimer\"><em>Radio Habana Cuba<\/em><\/a>.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">During the third phase of the trial, additional diagnostic procedures will be carried out to confirm patients are suffering from Alzheimer\u2019s, and not another form of dementia. In case another disease is confirmed, patients will not be included in the trial, but will be referred to specialists to receive adequate forms of care. During the trial, the effects of NeuralCIM will be compared to those of Donepezil, a dementia drug approved for use in the US. One third of the participants of the trial will be receiving NeuralCIM, one third Donepezil, and one third a combination of the two, explained Leslie P\u00e9rez Ruiz.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">As part of the trials, caregivers will be provided training for the administration of NeuralCIM \u2013 something that they will be expected to do once a day, every three days. All these steps are in line with the national strategy for people with dementia and Alzheimer\u2019s that was&nbsp;<a href=\"https:\/\/www.plenglish.com\/news\/2022\/04\/06\/strategy-for-dementia-and-alzheimers-care-presented-in-cuba\/\">announced&nbsp;<\/a>earlier this year, with the aim of developing tools and resources for improving the quality of life of the 170,000 people in Cuba who suffer from different forms of dementia.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In case NeuralCIM\u2019s trial is successful, it will once again show that the health path chosen by Cuba \u2013 based on the people\u2019s needs and non-profit sharing with other countries \u2013 can lead to impressive advances in medical science and health care.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">source by\u00a0<a href=\"https:\/\/peoplesdispatch.org\/2022\/08\/16\/cuba-strides-ahead-in-research-of-new-alzheimers-treatment\/\"><\/a><a href=\"https:\/\/peoplesdispatch.org\/author\/peoples-health-dispatch\/\">Peoples Health Dispatch<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cuban scientists have announced the next stage of research on NeuralCIM, a neuroprotective drug for Alzheimer\u2019s disease and other forms of dementia. Cuba continues to<a class=\"moretag\" href=\"https:\/\/www.cubasupport.ie\/latest\/cuba-strides-ahead-in-research-of-new-alzheimers-treatment\/\"> [&#8230;]<\/a><\/p>\n","protected":false},"author":101011,"featured_media":7587,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[43],"tags":[],"class_list":["post-7585","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-featured"],"jetpack_publicize_connections":[],"jetpack-related-posts":[{"id":5661,"url":"https:\/\/www.cubasupport.ie\/latest\/cuba-results-of-new-alzheimers-drug-revealed\/","url_meta":{"origin":7585,"position":0},"title":"Cuba: results of new Alzheimer\u2019s drug revealed","author":"Editorial Team","date":"December 17, 2021","format":false,"excerpt":"The drug is the result of studies carried out by the Center for Molecular Immunology (CIM) in collaboration with other BioCubaFarma institutions. Cuban scientists revealed the results of the phase II-III clinical trial of the Cuban product NeuroEpo in patients with mild\/moderate Alzheimer\u2019s disease, and they are encouraging, according to\u2026","rel":"","context":"In &quot;Cuba&quot;","block_context":{"text":"Cuba","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/laboratorista-en-Centro-de-Inmunologia-Molecular-CIM-750x563-1-750x536-1.jpeg?fit=750%2C536&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/laboratorista-en-Centro-de-Inmunologia-Molecular-CIM-750x563-1-750x536-1.jpeg?fit=750%2C536&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/laboratorista-en-Centro-de-Inmunologia-Molecular-CIM-750x563-1-750x536-1.jpeg?fit=750%2C536&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/laboratorista-en-Centro-de-Inmunologia-Molecular-CIM-750x563-1-750x536-1.jpeg?fit=750%2C536&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":7747,"url":"https:\/\/www.cubasupport.ie\/latest\/the-battle-against-alzheimers-disease-is-a-priority-for-cuba\/","url_meta":{"origin":7585,"position":1},"title":"The battle against Alzheimer&#8217;s disease is a priority for Cuba.","author":"Editorial Team","date":"October 11, 2022","format":false,"excerpt":"Alzheimer's disease is the most common form of dementia (a syndrome generally of a chronic or progressive nature, characterized by the deterioration of cognitive function). According to the World Health Organization (WHO), it is estimated that this type of dementia represents between 60% and 70% of overall cases.","rel":"","context":"In &quot;Cuba&quot;","block_context":{"text":"Cuba","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Screenshot-2022-10-11-at-22.50.24.png?fit=583%2C402&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Screenshot-2022-10-11-at-22.50.24.png?fit=583%2C402&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Screenshot-2022-10-11-at-22.50.24.png?fit=583%2C402&ssl=1&resize=525%2C300 1.5x"},"classes":[]},{"id":7861,"url":"https:\/\/www.cubasupport.ie\/latest\/cubans-trust-vaccines-and-how-theyre-helping-vaccinate-the-world\/","url_meta":{"origin":7585,"position":2},"title":"Cubans trust vaccines and how they\u2019re helping vaccinate the\u00a0world","author":"Editorial Team","date":"November 20, 2022","format":false,"excerpt":"Cuba continues to be at the forefront in the development of medical treatments for the benefit of mankind, especially in diseases such as Alzheimer's and Parkinson's disease. It is also willing to transfer its technologies to other nations on a non-profit basis, as has always been the motto of the\u2026","rel":"","context":"In &quot;Cuba&quot;","block_context":{"text":"Cuba","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Screenshot-2022-11-19-at-19.13.40.png?fit=394%2C259&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":5394,"url":"https:\/\/www.cubasupport.ie\/latest\/cuba-has-a-drug-against-alzheimers-disease\/","url_meta":{"origin":7585,"position":3},"title":"Cuba has a drug against Alzheimer&#8217;s disease","author":"Editorial Team","date":"November 1, 2021","format":false,"excerpt":"Cuba's Center for State Control of Medicines, Equipment and Medical Devices (CECMED) evaluates for registration the drug called NeuroEpo, an innovative product against Alzheimer's Disease. Scientists from Cuba have demonstrated its safety after long years of pharmaceutical, toxicological, efficacy in animals and diseases studies, and the clinical trial was conducted\u2026","rel":"","context":"In &quot;Cuba&quot;","block_context":{"text":"Cuba","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/older-people-cuba.jpeg?fit=600%2C883&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/older-people-cuba.jpeg?fit=600%2C883&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/older-people-cuba.jpeg?fit=600%2C883&ssl=1&resize=525%2C300 1.5x"},"classes":[]},{"id":3856,"url":"https:\/\/www.cubasupport.ie\/latest\/rhcs-english-language-broadcast-talk-about-the-cuban-vaccine-candidate\/","url_meta":{"origin":7585,"position":4},"title":"RHC&#8217;s English language broadcast, Talk about the Cuban vaccine candidate.","author":"Editorial Team","date":"March 4, 2021","format":false,"excerpt":"Soberana 02, the Cuban vaccine candidate that is been tested was just granted the authorization by the regulatory authority to enter a massive phase 3 trial that will take place in Havana\u2026 At the same time, Cuban scientists developed a new vaccine candidate for people who have had Covid\u2026 And\u2026","rel":"","context":"In &quot;Cuba&quot;","block_context":{"text":"Cuba","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Screen-Shot-2021-03-04-at-23.05.52.png?fit=722%2C403&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Screen-Shot-2021-03-04-at-23.05.52.png?fit=722%2C403&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Screen-Shot-2021-03-04-at-23.05.52.png?fit=722%2C403&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Screen-Shot-2021-03-04-at-23.05.52.png?fit=722%2C403&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":1329,"url":"https:\/\/www.cubasupport.ie\/latest\/cuban-medical-science-in-the-service-of-humanity\/","url_meta":{"origin":7585,"position":5},"title":"Cuban Medical Science in the Service of Humanity","author":"Editorial Team","date":"April 10, 2020","format":false,"excerpt":"By Helen Haffe Originally\u00a0 published in Fight Racism! Fight Imperialism! No 275, March\/April 2020 In late January 2020, the Chinese National Health Commission selected a Cuban anti-viral drug, Interferon Alfa 2b, among the treatments it would use for Covid-19 patients. This drug has been produced in Cuba by the Centre\u2026","rel":"","context":"In &quot;Featured&quot;","block_context":{"text":"Featured","link":"https:\/\/www.cubasupport.ie\/latest\/category\/news\/featured\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/cuban_doctor-new.jpg?fit=550%2C333&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/cuban_doctor-new.jpg?fit=550%2C333&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/cuban_doctor-new.jpg?fit=550%2C333&ssl=1&resize=525%2C300 1.5x"},"classes":[]}],"jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p3xdTY-1Yl","jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/older-people-1.jpeg?fit=700%2C457&ssl=1","_links":{"self":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts\/7585","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/users\/101011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/comments?post=7585"}],"version-history":[{"count":0,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts\/7585\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/media\/7587"}],"wp:attachment":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/media?parent=7585"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/categories?post=7585"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/tags?post=7585"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}